Development of a bone-targeted pH-sensitive liposomal formulation containing doxorubicin: physicochemical characterization, cytotoxicity and biodistribution evaluation in a mice model of bone metastasis

Descrição

Tipo

Artigo de periódico

Título alternativo

Primeiro orientador

Membros da banca

Resumo

Despite recent advances in cancer therapy, the treatment of bone tumors remains a major challenge. A possible underlying hypothesis, limitation, and unmet need may be the inability of therapeutics to penetrate into dense bone mineral, which can lead to poor efficacy and high toxicity, due to drug uptake in healthy organs. The development of nanostructured formulations with high affinity for bone could be an interesting approach to overcome these challenges.

Abstract

Assunto

Câncer, Lipossomos, Ossos

Palavras-chave

Hydroxyapatite-targeted formulations, Bisphosphonates, PH-responsive nanostructures, Bone-tumor treatment

Citação

Curso

Endereço externo

https://pubmed.ncbi.nlm.nih.gov/27563241/

Avaliação

Revisão

Suplementado Por

Referenciado Por